Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
about
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in womenA randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunctionThe role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicineTherapeutic Strategies to Treat Dry Eye in an Aging PopulationDry eye: an inflammatory ocular diseasePractical issues concerning tear protein assays in dry eyeDiagnosis of dry eye disease and emerging technologiesDesign of a superior cytokine antagonist for topical ophthalmic useTear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating proceduresSelenium compound protects corneal epithelium against oxidative stressDry eye and designer ophthalmics.Desiccating stress decreases apical corneal epithelial cell size--modulation by the metalloproteinase inhibitor doxycycline.Erratum: An experiment of the combined treatment of traditional Lei-huo-jiu therapy with Chinese medicine for the lacrimal gland of Sjögren's syndrome.Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome.Image-guided evaluation and monitoring of treatment response in patients with dry eye disease.The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease.Significance of lipid mediators in corneal injury and repair.Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery.Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseEffect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells.Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway.Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse modelCharacterization of effector T cells in dry eye disease.Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndromeDisruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis siccaTopical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model.Effects of extract of Buddleja officinalis on partial inflammation of lacrimal gland in castrated rabbits with dry eye.Dry eye disease: A review of diagnostic approaches and treatmentsEvaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells.Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study.Effect of inflammation on lacrimal gland function.Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucinsPreliminary study of the association between corneal histocytological changes and surgically induced astigmatism after phacoemulsification.Dry eye as a mucosal autoimmune disease.Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye diseaseSurfactant protein D contributes to ocular defense against Pseudomonas aeruginosa in a murine model of dry eye disease.
P2860
Q24537414-ED9BD778-F7BB-4A55-A058-1C827633EAD3Q24624909-20BA0BAB-69FF-40E6-8BFF-33C0F2E55B6EQ24649593-CDC5A877-602A-42EE-8368-6DEE9D6F9888Q26740411-096ECF5E-0B5D-4C50-B4D0-3448CDDF1390Q26822610-BF560045-D31F-4CBF-A386-C5454C6173D1Q26852044-F844F079-75C7-4EF5-96EA-FBA5A74A62DAQ27002082-F67450D4-6E61-4F99-BAF6-3B9DE7EA4E54Q27024827-407B2781-F44F-48DA-9452-01DD49EB4D51Q27676526-36BAF8C2-F0BE-4035-AC23-28444E512715Q28393435-6BD6E2E9-E21C-494A-A230-16870CBF52B9Q28484037-8E471B97-72B7-4ECC-8294-9934DB42960BQ30437137-4480C848-378F-457B-86E6-C1326A3BFDCDQ33362899-22DC0BF2-1D96-44FB-8937-396DA80A9783Q33560885-6DB15760-E276-4C88-B0A1-D99D4C02C441Q33595169-A834EAFF-6129-48FB-A7AF-A83E78EC1A56Q33686417-B150025E-0193-4D66-91D0-3202A2D19B15Q33765579-E20BBE85-B4CE-4E1C-BE8B-3F2C20113A74Q33784586-3C5BD4D4-4713-49EA-B97F-24ADB8F690ABQ33798707-35D7B4D8-F607-4F50-8404-41D01FCE205AQ33845460-E94DAA05-AB52-4FEF-AB0C-1CEDB2207B89Q33869200-B100BD97-0ED6-48FA-B166-6D03296C8C5DQ33894453-13E4F005-903F-4477-B6D4-3A586AD4F2D7Q33938235-E806C4BB-E193-4334-90CB-E1782D18C027Q34028408-59303D60-57CD-4268-9484-B5541E6E6E41Q34049326-2EA01BD9-2C60-4B6F-8BE8-0E7A0F11619CQ34065949-A5B4BCBA-B91E-4263-916A-C15F8D6BA526Q34086947-D5F86FB8-3137-400C-A28E-D6CB67FFFFF6Q34110644-39400CB1-4396-4276-BCBF-D1104EF257DCQ34206399-5316B46E-536D-4E29-9E8D-9B077429BEA6Q34206822-05C233DD-2D47-43E8-A562-5B443DE65B47Q34254464-0FF8793F-19DB-45BC-A7A1-4B7396B8C4BDQ34273384-84E27393-4C97-46AB-86CF-1FADED5AEB92Q34309959-EDAE455A-1FAF-49EB-8732-3ACBA23F38D1Q34325595-CD735B5F-35AF-49E9-9EB5-F5C7E7D1A8B1Q34338027-5FA7C038-CA89-4288-92F2-8364865A93E4Q34462636-D239C05E-AC56-440F-8322-526E541D752AQ34636157-80E7FD6B-E8E5-4058-86D9-4E3D15229444Q34647761-834E4EB9-4C94-4B9B-9C0D-179DC908D5A0Q34758079-CD71FF54-A392-4181-B5A2-7D20D7A3F8F6Q34770248-72411321-7C9D-4DC9-A654-83B23ADDFBF5
P2860
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@en
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@nl
type
label
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@en
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@nl
prefLabel
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@en
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@nl
P2093
P1476
Pro- and anti-inflammatory for ...... patients with dry-eye disease.
@en
P2093
P304
P407
P577
2001-09-01T00:00:00Z